p28 peptide sequence p28 peptide - peptides-as-therapeutics p28 peptide residues in the sequence range of 1-4, 7-11, and 22-23 Unraveling the p28 Peptide Sequence: A Deep Dive into its Anticancer Potential

p-11-4-peptide The p28 peptide sequence has emerged as a significant area of research in the field of oncology, particularly for its potential as an anticancer agentThis GPI signalsequencefunctions poorly in heterologous eukaryotic cells, causing CSP retention within internal cell organelles during genetic immunization.. This peptide is a 28 amino acid fragment of azurin, a protein originally identified in *Pseudomonas aeruginosa*. Its therapeutic promise stems from its ability to interact with critical cellular pathways, notably those involving the tumor suppressor protein p53.Azurin-based peptide p28 disrupts p53–HDM2 interactions Understanding the precise p28 peptide sequence is crucial for unlocking its full therapeutic potential and for developing targeted cancer treatments.

The full p28 peptide sequence is LSTAADMQGVVTDGMASGLDKDYLKPDD. This specific arrangement of amino acids dictates the peptide's unique properties, including its amphipathic nature and its capacity to adopt an α-helical structure. These characteristics are fundamental to its function as a cell penetrating peptide, allowing it to effectively enter cells, including cancer cells. Research has also identified specific regions within the p28 peptide that are critical for its activity.This GPI signalsequencefunctions poorly in heterologous eukaryotic cells, causing CSP retention within internal cell organelles during genetic immunization. For instance, p28 peptide residues in the sequence range of 1-4, 7-11, and 22-23 have been implicated in masking the hydrophobic pocket of HDM2, a protein that can promote the degradation of p53.

One of the key mechanisms by which p28 exerts its anticancer effects is by binding to p53.p28 peptide-functionalized PLGA nanoparticles - Scholar This interaction is not straightforward; rather, p28 binds to a specific motif within the DNA binding domain (DBD) of p53. This binding event is significant because it can inhibit COP1-mediated degradation of p53, thereby increasing intracellular levels of this vital tumor suppressor. This disruption of the p53-HDM2 interactions is a critical aspect of p28's mechanism of action. Some studies suggest that the COOH terminal 10–12 aa of p28 play a role in inhibiting cell growth and promoting apoptosis, further highlighting the importance of the precise amino acid arrangement.作者：H Abuei·被引用次数：11—Thep28is a small-sized cell-penetratingpeptidederived from bacterial protein azurin and can function as a cancer-specific anti-proliferative agent.

The origin of the p28 peptide is from the bacterial protein azurin, which is a redox protein. The specific fragment used as a therapeutic agent comprises amino acids 50-77 of azurinThepeptidecorresponding to the bold underlined (55–75)sequencewas found to react with antibodies to Ehrlichia as well as to induce antibody production. (B) .... This azurin-derived cell-penetrating peptide p28 is a water-soluble, amphipathic molecule with a molecular weight of approximately 2作者：J Yang·2021—Consequently, it is impossible to rationally modify the amino acidsequenceofp28to further enhance the interaction betweenp28and p53 and to ....9 kDaAzurin-based peptide p28 disrupts p53–HDM2 interactions. Its ability to be preferentially taken up by human cancer cell lines, including breast cancer cell lines, is a key attribute. The p28 peptide derived from Pseudomonas aeruginosa azurin has shown anticancer activity after binding to the p53 protein and has progressed into Phase I clinical trials, underscoring its therapeutic relevance.

Further exploration of the p28 peptide sequence has revealed that specific modifications can be made to enhance its interaction with p53. Researchers are investigating how to rationally modify the amino acid sequence of p28 to further boost this interaction. For example, the sequence Leu-Ser-Thr-Ala-Ala-Asp-Met-Gln-Gly-Val-Val-Thr-Asp-Gly-Met-Ala is a representation of the peptide's amino acid composition, and variations or additions, such as synthesizing a new p28 peptide sequence by adding a cysteine to the hydrophilic region, are being explored to optimize its function.

The therapeutic applications of p28 extend beyond direct administration.p17366 · p28_vaccw It has been incorporated into drug delivery systems, such as p28 peptide-functionalized PLGA nanoparticles, to improve its efficacy and targeting.Azurin p28 peptide | p53: Tocris Bioscience This approach aims to enhance the delivery of p28 to tumor sites. The peptide's ability to arrest the cell cycle and induce apoptosis in cancer cells makes it a promising candidate for various oncological indications. While the full p28 peptide sequence is LSTAADMQGVVTDGMASGLDKDYLKPDD, specific shorter regions, like the sequence corresponding to amino acids 50-67 (which constitutes p18), have also been identified as minimal motifs responsible for preferential entry into cancer cellsThe amino acidsequencesof Leptulipin andp28were joined via a rigid linker to maintain structural and functional integrity. Secondary and tertiary structure ....

In summary, the p28 peptide sequence represents a significant advancement in peptide-based cancer therapy.作者：AR Garizo·2021·被引用次数：62—Among them,p28(28 amino acids; 2.8 kDa), a CPP derived from the bacterial protein azurin (128 amino acids; 14 kDa), is an interesting molecule ... Its interaction with p53, its cell-penetrating capabilities, and its origin from the bacterial protein azurin collectively contribute to its potential as an anticancer agent. Ongoing research continues to refine our understanding of its mechanism of action and to explore novel applications, solidifying its importance in the pursuit of more effective cancer treatments. The p28 peptide is not merely a sequence of amino acids; it is a key player in modulating crucial cellular pathways with the aim of combating cancer.